Search

everythinglearnresearchcommunity

for

Search:↓

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

An infant developed excessive hair growth after a bone marrow transplant and cyclosporine treatment.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Combination therapy may be more effective for difficult-to-treat scalp conditions.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Clascoterone is safe for the heart, even at high doses.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Ulcerative sarcoidosis in body folds is rare and improved with prednisone and hydroxychloroquine.

Systemic corticosteroids can cause unusual skin issues in people with juvenile rheumatoid arthritis.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.